" /> Cerebral creatine deficiency syndrome 2 - CISMeF





Preferred Label : Cerebral creatine deficiency syndrome 2;

Symbol : CCDS2;

CISMeF acronym : CCDS2;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Creatine deficiency syndrome due to gamt deficiency; Gamt deficiency; Guanidinoacetate methyltransferase deficiency;

Description : Guanidinoacetate methyltransferase deficiency is an autosomal recessive disorder characterized by developmental delay/regression, mental retardation, severe disturbance of expressive and cognitive speech, intractable seizures and movement disturbances, severe depletion of creatine/phosphocreatine in the brain, and accumulation of guanidinoacetic acid (GAA) in brain and body fluids (summary by Schulze, 2003). For a general phenotypic description and a discussion of genetic heterogeneity of CCDS, see CCDS1 (300352).;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the guanidinoacetate methyltransferase gene (GAMT, 601240.0001);

Laboratory abnormalities : Extremely low creatine excretion; Guanidinoacetate methyltransferase (GAMT) deficiency; Low CSF creatinine; Deficiency of creatine phosphate in brain; Accumulation of guanidinoacetate in brain; Low CSF creatine;

Prefixed ID : #612736;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.